Search Results
Search results for "GREGORY TALL"
Results found for "GREGORY TALL"
- 📰 GPCR Weekly News, October 23 to 29, 2023
We're proud sponsors and can't wait to connect with all of you. See you there! Find speaker details on the Live Talks page and mark your calendar HERE.
- 📰 GPCR Weekly News, April 17 to 23, 2023
Submit your interest in giving a talk or presenting a poster to Hello@DrGPCR.com. Don't miss out!
- Chemical signaling regulates axon regeneration via the GPCR-Gqα pathway in Caenorhabditis elegans
C. elegans secretes a family of small-molecule pheromones called ascarosides, which serve various functions
- 📰 GPCR Weekly News - January 2 to 8, 2023
Sherwin Sells 30,000 Shares STALICLA signs agreement with Novartis on neurodevelopmental disorders Call
- 📰 GPCR Weekly News
Special report 2022: Meet 20 women blazing trails in biopharma R&D ERNEST - 2022 Scientific Outputs Call
- How Collaboration Drives GPCR Discoveries
No one person can be excellent at all of it — and pretending otherwise slows discovery. about trust — the kind of trust built when collaborators confirm your data, replicate your results, and call
- What's Going On with GPCRs?! Find Out in This Week's Update! ⦿ Nov 4 - 10, 2024
Join us for this week’s update, where you’ll find all the latest breakthroughs and exciting developments Liangliang Zhou , Chungong Yu , Haicang Zhang , Dongbo Bu 🤩 Seriously, why would you want to miss out on all As a premium member , you have access to all the complimentary perks as well as: Dr. GPCR University 🎥 Access to the recorded classes of GPCR Courses and talks from Symposia 💲 Discounted
- Class B1 GPCR Dimerization: Unveiling Its Role in Receptor Function and Signaling
stable, are believed to influence the function and regulation of GPCRs—a process known as receptor cross-talk
- Orthosteric vs. Allosteric Interactions: The Silent Decider of Safety and Success
orthosteric and allosteric interactions as interchangeable, you’re leaving precision (and money) on the table
- Optimizing HTRF Assays with Fluorescent Ligands: Time-Resolved Fluorescence in GPCR Research
The donors act as light-harvesting antennas, capturing light from all directions, unlike the dipole-dipole This has been done in assays tracking IP1 and cAMP to detect biased agonism in GPCR ligands Table 1.
- Why Opposing Processes Matter for Your Next GPCR Drug
Drug pipelines live and die by your ability to make fast, accurate calls. A renin inhibitor that lowers blood pressure in healthy volunteers might not drop blood pressure at all Reflexes as Drug Design Partners Not all reflexes are enemies. Some can make a mediocre drug shine. Ligands come and go, feedback loops kick in, and what you see in vitro rarely tells the whole story.
- Quantifying Receptor Selectivity in Modern Drug Discovery
A compound shows no response in one assay, and we call it “selective.”
- 📰 GPCR Buzz: August 5-11, 2024 | Top Highlights from DrGPCR University!
GPCR University offers two live courses this fall that you won’t want to miss.
- 📰 GPCR Weekly News, May 22 to 28, 2023
You can now watch the live talk recordings from the previous symposiums, check them out here.
- Exploring the Breakthroughs in GPCR Research
interactions of the serotonin1A receptor Industry News Neurocrine Biosciences Announces Conference Call
- 📰 GPCR Weekly News, May 1 to 7, 2023
Industry News Addex Therapeutics to Release Q1 2023 Financial Results and Host Conference Call on May Beat Expectations, EPS Lags “As Precision Medicine is critical, we cannot think about one size fits all
- 📰 GPCR Weekly News, June 24 to 30, 2024
GPCR Ecosystem this fall.
- 📰 GPCR Weekly News, October 16 to 22, 2023
You can find more information about them on the Live Talks page and mark your calendar HERE.
- 📰 GPCR Weekly News, July 17 to July 23, 2023
Premium members can always go back and watch the recorded talks at any time. Submit a 1-minute abstract video and tell us more about your project in this form.
- 📰 GPCR Weekly News, January 23 to 29, 2023
development of cachexia therapeutics Sosei Heptares Webinar Presentation for FY2022 Financial Results Call
- 📰 GPCR Weekly News, January 16 to 22, 2023
Christopher Prior, as CEO and Reports Recent Drug Discovery Highlights Call for GPCR Papers GPCRs: Signal
- 📰 GPCR Weekly News - January 9 to 15, 2023
collaborations GPCR Therapeutics Announces Launch of US Phase 2 Trial of GPC-100 in Multiple Myeloma Call
- Transformative GPCR Insights: Unleash New Horizons in Science | Sep 9 - 15, 2024
With just one week left, becoming a premium member is all it takes to benefit from this discount! Crinetics Pharmaceuticals Announces September 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Call
- 📰 GPCR Weekly News, December 4 to 10, 2023
Nouvelle-Aquitaine Region Governor GPCR Events, Meetings, and Webinars January 16 - 19, 2024 | 23rd Annual PEP Talk
- Beyond Clearance: The Strategic Power of Irreversible Drug Binding
The on-rate/off-rate balance matters: too tight, and penetration stalls; too loose, and efficacy dissipates Washout experiments don’t tell the full story.
- 📰 GPCR Weekly News, August 21 to 27, 2023
Submit poster abstracts via this form; short talks will be selected.
- 📰 GPCR Weekly News, August 14 to 20, 2023
Submit poster abstracts using this form; short talks will be selected from submissions.
- 📰 GPCR Weekly News, February 13 to 19, 2023
Artificial Intelligence for Drug Discovery Call for GPCR Papers GPCRs: Signal Transduction.
- 📰 GPCR Weekly News, February 6 to 12, 2023
Listing Rule 5635(c)(4) arcoscreen is one of the 13 biotech companies to discover in western in 2023 Call
- 📰 GPCR Weekly News, April 3 to 9, 2023
The program is under construction but if you’d like to give a talk or present a poster, email us at Hello











